STERIMED
ActiveSTERIMED has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €759k and a net result of €309k. Equity is growing by ~32.1% per year across the filed fiscal years. Its solvency ranks better than 45% of 7921 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
94
/ 100
Excellent▲ +18 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+97
Solvency76▲+11
Growth78=
Stability100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €70k at 30 days acceptable
Liquidity ample (current ratio 1.67 against 1.53 in 2024), but 60.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
39.3%
Return on assets
16%
Age of the figures
14 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 22-12-2025, 40 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
40 d early
2024
44 d early
2023
41 d early
2022
36 d early
2021
42 d early
2020
44 d early
2019
39 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close14-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€759k▲ 51.8%
2024 · €500k
2019: €153k
2020: €164k
2021: €204k
2022: €329k
2023: €512k
2024: €500k
2019 → 2025
Total assets
€1.93M▲ 29.9%
2024 · €1.49M
2019: €996k
2020: €1.08M
2021: €1.02M
2022: €1.40M
2023: €1.44M
2024: €1.49M
2019 → 2025
Net result
€309k▲ 9,171%
2024 · €3k
2019: €-40k
2020: €12k
2021: €40k
2022: €126k
2023: €182k
2024: €3k
2019 → 2025
Working capital
€548k▲ 75.6%
2024 · €312k
2019: €87k
2020: €88k
2021: €98k
2022: €197k
2023: €367k
2024: €312k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€204k-€329k▲ 61.7%€512k▲ 55.3%€500k▼ 2.3%€759k▲ 51.8%
Operating result€62k-€183k▲ 197%€262k▲ 43.5%€23k▼ 91.1%€426k▲ 1,715%
Net result€40k-€126k▲ 217%€182k▲ 45.1%€3k▼ 98.2%€309k▲ 9,171%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 1,715% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.93M
Fixed assets
€565k▼ 4.1%
Current assets
€1.37M▲ 52.1%
Equity and liabilities €1.93M
Equity
€759k▲ 51.8%
Debt
€1.17M▲ 18.7%
The debt ratio falls from 66.4% to 60.7%: equity grows faster than debt.
Key figures and ratios
EBITDA
€487k▲
2024 · €84k
Cash flow
€370k▲
2024 · €64k
Solvency
39.3%▲
2024 · 33.6%
Current ratio
1.67▲
2024 · 1.53
Quick ratio
1.59▲
2024 · 1.41
Debt / equity
1.54▼
2024 · 1.98
ROE
40.7%▲
2024 · 0.7%
ROA
16.0%▲
2024 · 0.2%
Interest coverage
25.60▲
2024 · 4.66
Debt
€1.17M▲
2024 · €988k
Debt ≤ 1 year
€819k▲
2024 · €587k
Debt > 1 year
€354k▼
2024 · €401k
Income taxes
€109k▲
2024 · €9k
Staff costs
€241k▼
2024 · €270k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.49M€1.93M▲
Fixed assets21/28€589k€565k▼
Tangible fixed assets22/27€542k€517k▼
Land and buildings22€447k€422k▼
Plant, machinery and equipment23-€2k
Furniture and vehicles24€73k€67k▼
Other tangible fixed assets26€22k€26k▲
Financial fixed assets28€47k€48k▲
Current assets29/58€898k€1.37M▲
Stocks and contracts in progress3€71k€68k▼
Stocks30/36€71k€68k▼
Amounts receivable within one year40/41€391k€409k▲
Trade receivables40€389k€408k▲
Other amounts receivable41€2k€724▼
Cash at bank and in hand54/58€428k€887k▲
Deferred charges and accrued income490/1€9k€3k▼
Equity and liabilities
Total equity and liabilities10/49€1.49M€1.93M▲
Equity10/15€500k€759k▲
Contributions10/11€19k€19k=
Reserves13€121k€121k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Tax-exempt reserves132€19k€19k=
Distributable reserves133€100k€100k=
Profit (loss) carried forward14€361k€620k▲
Amounts payable17/49€988k€1.17M▲
Amounts payable after more than one year17€401k€354k▼
Financial debts170/4€401k€354k▼
Amounts payable within one year42/48€587k€819k▲
Current portion of amounts payable after more than one year42€56k€84k▲
Trade debts44€158k€158k▼
Suppliers440/4€158k€158k▼
Advances received on contracts in progress46€5k-
Taxes, remuneration and social security45€104k€308k▲
Taxes450/3€75k€278k▲
Remuneration and social security454/9€30k€30k▲
Other amounts payable47/48€262k€270k▲
Accrued charges and deferred income492/3€263-
Income statement
Code20242025
Remuneration, social security and pensions62€270k€241k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€61k€61k▲
Other operating charges640/8€7k€6k▼
Gross operating margin9900€362k€734k▲
Operating profit (loss)9901€23k€426k▲
Financial income75/76B€7k€11k▲
Recurring financial income75€7k€11k▲
Financial charges65/66B€18k€19k▲
Recurring financial charges65€18k€19k▲
Profit (loss) for the period before taxes9903€12k€418k▲
Income taxes67/77€9k€109k▲
Profit (loss) for the period9904€3k€309k▲
Profit (loss) for the period to be appropriated9905€3k€309k▲
Appropriation of the result
Profit (loss) to be appropriated9906€361k€670k▲
Profit (loss) brought forward from the previous period14P€358k€361k▲
Transfer from equity791/2€15k€50k▲
Transfer to equity691/2-€50k
To other reserves6921-€50k
Profit to be distributed694/7€15k€50k▲
Return on contributions (dividend)694€15k€50k▲
Social balance
Average headcount (FTE)90874.84.4▼
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
22-12
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
30-06
Financial
Highest result since 2019net €309k ▲9171%
Operating result €426k, net result €309k, both a record.
2024
18-12
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2023
21-12
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
30-06
Financial
Equity above €500kEq €512k ▲55.3%
4 profitable years in a row build equity to €512k.
2022
26-12
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2021
20-12
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
30-06
Financial
Equity above €200kEq €204k ▲24.1%
2 profitable years in a row build equity to €204k.
2020
18-12
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
30-06
Financial
Back to profitnet €12k
Net result €12k after one loss-making year.
2019
23-12
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
21-12
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
24-12
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2016
22-12
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Riemst · 1 establishment unit since 2003
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Biesenakkers 13770 RiemstGround area
868 m²
Building footprint
441 m²
Parcel 73066A1772/00B000, Flanders. Linked by address, not a title deed.
1 establishment unit
STERIMED
since 20032.135.619.009
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 73066A1772/00B000 | Flanders | 868 m² | 1 · 441 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 5 entries · 12,744 EUR awarded · 12,745 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 2 | 3,944 EUR | 3,944 EUR |
| 2024 | 1 | 3,434 EUR | 3,774 EUR |
| 2023 | 1 | 4,817 EUR | 4,478 EUR |
| 2022 | 1 | 549 EUR | 549 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Retroactieve investeringspremie voor eigenaars van zonnepanelen na afschaffing van terugdraaiende teller
Similar companies · same sector, comparable size
Farmadistri
BE 0716.742.995
Oudenburg · Eq €760k
SENOR
BE 0886.286.822
Ronse · Eq €763k
MEDIM
BE 0745.915.647
Kruisem · Eq €766k
Corin Belgium
BE 0663.533.448
Aarschot · Eq €751k
BAUSCH & LOMB PHARMA
BE 0439.621.618
Wavre · Eq €751k
Of 1,894 companies in sector 46460 we hold annual accounts for 1,114. 763 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded29-12-2003
Fiscal year end30-06
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
77225Rental and leasing activities
Sources
Crossroads Bank for EnterprisesNational Bank · 21 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.